(Q57693948)
Statements
Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials (English)
David Olmos
Timothy A Yap
Christophe Massard
Lorna Pope
Juliet Dukes
Dionysis Papadatos-Pastos
Philippa Grainger
Stan B Kaye
Johann S de Bono